[Comparative open trial of carbamazepine and slow-release carbamazepine in epilepsy in adults].
A multicentre open therapeutic trial comparing carbamazepine with slow-release carbamazepine was conducted in 114 epileptic patients older than 12 years. The patients received the two products successively during two periods of 1 month each. With slow-release carbamazepine the number of doses could be reduced to 2 per day without decrease in effectiveness and with less side-effects. The twice-a-day dosage should result in better compliance and consequently in a better quality of treatment in the long term.
Remy
C
C
Centre médical de la Teppe, Tain L'Hermitage.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D002220:Carbamazepine / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic
D003692:Delayed-Action Preparations; D002220:Carbamazepine
Etude ouverte comparative de la carbamazépine et de la carbamazépine à libération prolongée dans l'épilepsie de l'adulte.